Nicox S.A. Faces Investor Doubts as Ophthalmic Growth Falters Amid Financial Struggles
Nicox S.A.: A biotech eye‑care innovator battling declining stock and negative earnings while seeking growth through high‑profile partnerships.
2 minutes to read
NICOX SA